During the past decade, William E Kahlert Regional Cancer Center/Sinai Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 11 clinical trials were completed, i.e. on average, 36.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 10 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "William E Kahlert Regional Cancer Center/Sinai Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 11 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "National Cancer Institute (NCI)" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "Celgene" with 5 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "William E Kahlert Regional Cancer Center/Sinai Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "William E Kahlert Regional Cancer Center/Sinai Hospital" are "Invasive Breast Carcinoma" (5 trials), "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Breast Cancer" (4 trials), "Recurrent Lung Non-Small Cell Carcinoma" (4 trials) and "Stage IIIA Breast Cancer" (4 trials). Many other conditions were trialed in "William E Kahlert Regional Cancer Center/Sinai Hospital" in a lesser frequency.

Most popular intervention types in "William E Kahlert Regional Cancer Center/Sinai Hospital" are "Drug" (31 trials), "Other" (22 trials), "Biological" (9 trials), "Procedure" (6 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Quality-of-Life Assessment" (7 trials), "Carboplatin" (6 trials), "Questionnaire Administration" (6 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "William E Kahlert Regional Cancer Center/Sinai Hospital" are 34 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "William E Kahlert Regional Cancer Center/Sinai Hospital". undefined are not yet recruiting, 12 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in William E Kahlert Regional Cancer Center/Sinai Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in William E Kahlert Regional Cancer Center/Sinai Hospital, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".